Bar Code Technologies for Drugs and Biological Products: Retrospective Review Under Executive Order 13563
Document ID: FDA-2011-N-0719-0001
Comments
Total: 30
-
Daniel James Healy - Comment
Posted : 12/21/2011 ID ：FDA-2011-N-0719-0002 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
Dennis Anthony Tribble - Comment
Posted : 12/21/2011 ID ：FDA-2011-N-0719-0003 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
Jeffery Eugene Thompson - Comment
Posted : 12/21/2011 ID ：FDA-2011-N-0719-0004 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
Mark Neuenschwander - Comment
Posted : 12/21/2011 ID ：FDA-2011-N-0719-0005 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
Emma R Surber - Comment
Posted : 12/21/2011 ID ：FDA-2011-N-0719-0006 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
Chuck Evanhoe - Comment
Posted : 01/24/2012 ID ：FDA-2011-N-0719-0007 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
Annette Schlueter - Comment
Posted : 01/24/2012 ID ：FDA-2011-N-0719-0008 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
Lance Rodewald, M.D. - Comment
Posted : 01/24/2012 ID ：FDA-2011-N-0719-0009 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
Mark Goldberger - Comment
Posted : 01/24/2012 ID ：FDA-2011-N-0719-0010 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
Anita Ducca - Comment
Posted : 01/24/2012 ID ：FDA-2011-N-0719-0011 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
Nancy Payne - Comment
Posted : 01/24/2012 ID ：FDA-2011-N-0719-0012 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
Suresh Jadhav - Comment
Posted : 01/24/2012 ID ：FDA-2011-N-0719-0013 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
Pat Distler - Comment
Posted : 01/24/2012 ID ：FDA-2011-N-0719-0014 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
Susan Sharpe - Comment
Posted : 01/24/2012 ID ：FDA-2011-N-0719-0015 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
Christopter Topoleski - Comment
Posted : 01/24/2012 ID ：FDA-2011-N-0719-0016 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
John Roberts - Comment
Posted : 01/24/2012 ID ：FDA-2011-N-0719-0017 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
Maria Jacobs - Comment
Posted : 01/24/2012 ID ：FDA-2011-N-0719-0018 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
Allison Mueller - Comment
Posted : 01/24/2012 ID ：FDA-2011-N-0719-0019 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
P. Rigney, Jr. - Comment
Posted : 01/24/2012 ID ：FDA-2011-N-0719-0020 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
Mary Gustafson - Comment
Posted : 01/24/2012 ID ：FDA-2011-N-0719-0021 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
Kendra martello - Comment
Posted : 01/24/2012 ID ：FDA-2011-N-0719-0022 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
Jacqlyn Riposo - Comment
Posted : 01/24/2012 ID ：FDA-2011-N-0719-0023 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
Andrew Emmett - Comment
Posted : 01/24/2012 ID ：FDA-2011-N-0719-0024 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
James Stigall - Comment
Posted : 01/24/2012 ID ：FDA-2011-N-0719-0025 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
AABB - Comment
Posted : 02/03/2012 ID ：FDA-2011-N-0719-0026 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
Center for Disease Control and Prevention (CDC) - Comment
Posted : 02/03/2012 ID ：FDA-2011-N-0719-0027 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
John Joseph Roberts - Comment
Posted : 02/28/2012 ID ：FDA-2011-N-0719-0028 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
John Joseph Roberts - Comment
Posted : 02/28/2012 ID ：FDA-2011-N-0719-0029 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
AIM - Comment
Posted : 02/28/2012 ID ：FDA-2011-N-0719-0030 Agency : FDA -
Feb 23,2012 11:59 PM ET
-
GS1 US - Comment
Posted : 11/27/2012 ID ：FDA-2011-N-0719-0031 Agency : FDA -
Feb 23,2012 11:59 PM ET